The cholinergic anti-inflammatory pathway inhibits inflammation without lymphocyte relay
myeloid cells
splenic nerve stimulation
Neurosciences. Biological psychiatry. Neuropsychiatry
cholinergic anti-inflammatory pathway
CD4+ T lymphocytes
beta2 adrenergic receptor
RC321-571
Neuroscience
DOI:
10.3389/fnins.2023.1125492
Publication Date:
2023-04-14T04:56:41Z
AUTHORS (17)
ABSTRACT
The magnitude of innate inflammatory immune responses is dependent on interactions between peripheral neural and cells. In particular, a cholinergic anti-inflammatory pathway (CAP) has been identified in the spleen whereby noradrenaline (NA) released by splenic nerves binds to ß2-adrenergic receptors (β2-AR) CD4+ T cells which, turn, release acetylcholine (ACh). binding ACh α7 (α7-AChR) expressed macrophages inhibits production cytokines, including tumor necrosis factor (TNF). However, role ACh-secreting T-cells CAP still controversial largely based absence this mice lacking (nude, FoxN1-/-). Using four conscious, non-lymphopenic transgenic mouse models, we found that, rather than acting T-cells, NA nerve terminals acts directly onto β2-AR myeloid exert effect. We also show while larger doses LPS are needed trigger nude strain compared other strains, TNF can be inhibited these animals T-cell stimulating either vagus or nerve. demonstrate that dispensable for after antibody-mediated depletion wild type mice. Furthermore, NA-mediated inhibition vitro LPS-induced secretion human porcine splenocytes does not require α7-AChR signaling. Altogether our data activation stimulation mainly mediated direct macrophages, suggest same mechanism at play species.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (23)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....